Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory OutcomesBarbara K. Smith, Barry J. Byrne, Saleem Islam et al.|Human Gene Therapy|2013Cited by 156
Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV- <i>hGAA</i> ) Gene Therapy in Children Affected by Pompe DiseaseManuela Corti, Barry J. Byrne, Cristina Liberati et al.|Human Gene Therapy Clinical Development|2017Cited by 118
Pompe disease gene therapyBarry J. Byrne, Cathryn Mah, Darin J. Falk et al.|Human Molecular Genetics|2011Cited by 93
Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice With Established DiseaseCathryn Mah, Barry J. Byrne, Darin J. Falk et al.|Molecular Therapy|2010Cited by 76
Retrograde Gene Delivery to Hypoglossal Motoneurons Using Adeno-Associated Virus Serotype 9Mai K. ElMallah, David D. Fuller, Darin J. Falk et al.|Human Gene Therapy Methods|2012Cited by 44